Athena Diagnostics, Inc. v. Mayo Collaborative Services, No. 17-2508 (Fed. Cir. Feb. 6, 2019)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Athena Diagnostics, Inc., Oxford University Innova- tion Ltd., and the Max-Planck-Gesellschaft zur Forderung der Wissenschaften E.V. (collectively, “Athena”) appeal from the order of the United States District Court for the District of Massachusetts holding that claims 6 –9 of U.S. Patent 7,267,820 ( the “’820 patent”) are invalid under 35 U.S.C. § 101 and dismissing Athena’s complaint under Rule 12(b)(6). Athena Diagnostics, Inc. v. Mayo Collabora- tive Servs., LLC, 275 F. Supp. 3d 306 (D. Mass. 2017) (“De- cision”).